Hummingbird Ventures

Former MIT graduates launch spatial biology-focused startup to test hundreds of CAR-T cell therapies at once in mice. Check out my exclusive story for Endpoints News on the launch of Waypoint Bio, founded and led by Xinchen Wang and David Phizicky. https://lnkd.in/esuPUJak #biotech #startup #CART #CARTcelltherapy #celltherapy #spatialbiology #pooledscreening #invivomodels #mousemodels #preclinical #cancer #oncology #autoimmunedisease

Today we are excited to make two big announcements! First, we have launched a new collaboration with Microsoft! This collaboration includes access to the computing resources we need to power our novel drug discovery platform and to scale our generative AI models. And speaking of models, the second announcement is that we’ve released the details of our Foundation Model, PRISM (Pretrained Representations Informed by Spectral Masking). PRISM takes advantage of the latest advancements in machine learning that let models learn from unlabeled data. This allowed us to train it on the largest dataset of mass spectra ever assembled – over one billion! – which has improved our ability to translate cryptic mass spectra data into predictions of chemical structures and properties. These predictions point our chemists to the most attractive and amenable molecules in nature to turn into new, impactful medicines. For more details on the collaboration, check out the press release: https://bit.ly/450dnGE And to learn about PRISM, please read our blog post: https://lnkd.in/g3UMiTA4

Decoding Bio's Snapshot '24 is here! This time, we asked our friends to discuss the most consequential papers published in the past 18 months across five widely-discussed themes in biology: Generative AI by David Li, Patrick Malone, & Philipp Lorenz Biosecurity by Morgan Cheatham & Niko McCarty Cell-Based Medicine by Andrew Pannu & Elliot Hershberg Immunology by Ketan Yerneni & Zahra Khwaja Software Infrastructure by Dr. Shelby In each of the themes, you will find comments on why this particular publication matters, its impact on the field, and potential challenges in the space. The extended Decoding Bio Community reads thousands of these papers per year spanning a broad range of topics, from how quantum physical interactions affect biological processes to how technology affects human behavior. We hope that through our analysis, Decoding Bio can uncover the signal — important scientific advances — from the noise of millions of publications from a few key papers that we feel are changing the scientific landscape. Masterfully designed by Bunsen cc Amee Kapadia

Decoding Bio just took an evolutionary leap! We started Decoding Bio to fill a gap in the conversation in the expansive biotech landscape. Our mission is simple — to translate complex science into an accessible format and bring people interested in advancing human health together. We strive to transform Decoding Bio into a community focused on exploring the ever-expanding boundaries of biology. With this in mind, we're also announcing this years AI x Bio Summit at the NYSE. We have an incredible roster of speakers and participants. If you're interested in attending you'll find the registration form in the Substack article below. https://lnkd.in/e7XQZzAQ Amee Kapadia Patrick Malone, Morgan Cheatham Ketan Yerneni Zahra Khwaja Bunsen Matthew Smith Ben Kellogg Susie Foster Benten Woodring Devin Fountain

We're expanding our India/Southeast Asia team at Hummingbird Ventures with an analyst/associate hire. If you find yourself diving deep into tech trends in your free time, enjoy building long-term relationships with founders, and are excited by the prospect of working with a global team, this is the right role for you! We've been privileged to work with exceptional companies early on in their journey - OneCard, Jupiter, Eka Care, Aspire, and Vance, among others - and we continue to deepen our presence across growing markets like India, Indonesia, and Singapore. Shoot us a resume at recruitment@hummingbird.vc using the subject line “APAC Investing", if interested in exploring the role 🙏

Hummingbird recently backed a team working on big-scale energy storage. They are building an entirely new mechanical energy storage technology to decarbonize the world's grid. We are currently looking for hardware engineers who love working in a fast-paced environment on a product that will move the needle in the physical world. Competitive compensation and one of the best deep tech teams we’ve met in Europe. Please get in touch if interested!

7 months ago I celebrated #PhDone. Many people have been asking what I’ve been up to. Now it’s time to pull the curtain: Jakob Steinfeldt, MD and I are launching Pheiron - a platform to provide predictive evidence on clinical efficacy. Drug development is broken. Over 90% of drug development programs entering clinical development fail. R&D costs are exploding. The root of that problem? Insufficient ability to anticipate clinical utility in real humans. We build Pheiron to change that - in silico and at scale. Basing decisions on the right evidence is critical for success. Quality determines time and cost. Our platform provides predictive evidence on clinical efficacy to select the right target for the disease and the right population for the trial. Find out more about our vision and why we’re building Pheiron on our blog: https://lnkd.in/efYchG8C If this resonates with you, we’d love to chat! Also, we’re currently #hiring. Check out our open positions: https://lnkd.in/ev4MfZYq Blog post: https://lnkd.in/efYchG8C Open positions: https://lnkd.in/ev4MfZYq

Super excited to announce that we've raised $40m, led by Dimension with participation from A.P. Moller Holding, Octopus Ventures, Hummingbird Ventures, Isomer Capital, Aldea Ventures and Possible Ventures. The last year at Automata has been incredibly fast paced, we’ve deployed and are deploying some incredible systems, signing up new users working on everything from oncology, synthetic materials and new therapeutics / drug development and we're building some great products we can’t wait to show off soon! As always a massive shoutout to the incredible team here at Automata as well as those joining and staying on for the journey: Nan Li, Chetan M. & Alex Wang, Lola Wajskop & Pablo Lubroth, Joe Stringer & Jessica McCreadie, Chris Wade, Chris Hitchen, J.D. Englehart, Claudio E. P. Jordán, Mish Mashkautsan, Alfonso Bassols and Charles GIESEN Ive tried to capture some of Automata's journey and whats next in a 5min read below. Last but not least, get in touch if you're interested! We're just getting started 🚀 🤖 🧬 https://lnkd.in/eN6zhAnY